Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Transgenic mouse lacking PAPP-A activity

Transgenic mouse lacking PAPP-A activity

US Patent 7220892 · Granted May 22, 2007

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Treatment of a senescence-associated ocular disease or disorder using a Bcl-xL s2025
Treating cardiovascular disease by selectively eliminating senescent cells2024
Treating cognitive decline and other neurodegenerative conditions by selectively2022
Removing senescent cells from a mixed cell population or tissue using a phosphoi2019
Compositions of matter for treatment of ophthalmic conditions by selectively rem2019
Unit dose of an aryl sulfonamide that is effective for treating eye disease and 2019
Methods and compositions for killing senescent cells and for treating senescence2019
Treating atherosclerosis by removing senescent foam cell macrophages from athero2019
Use of sulfonamide inhibitors of BCL-2 and BCL-xL to treat ophthalmic disease by2019
Treating pulmonary conditions by selectively removing senescent cells from the l2019
Increasing healthy lifespan and delaying progression of age-related phenotypes b2019
Treatment of ophthalmic conditions by selectively removing senescent cells from 2018